LifeVantage Announces Shares Repurchase Program

LifeVantage Announces Shares Repurchase Program

Company Authorized Repurchase of Up to $5 Million in Shares of Its Common
Stock

SALT LAKE CITY, Dec. 14, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation
(Nasdaq:LFVN), a company dedicated to helping people achieve healthy living
through a combination of a compelling business opportunity and scientifically
validated products, including its patented dietary supplement Protandim^®, the
Nrf2 Synergizer^®, announced today that its Board of Directors approved a
share repurchase program that authorizes the Company to utilize up to $5
million to purchase shares of its common stock. Any such repurchases will be
made out of existing cash or free cash flow from continuing operations.

The repurchase program permits LifeVantage to purchase shares from time to
time through a variety of methods, including in the open market, through
privately negotiated transactions or other means as determined by the
company's management, in accordance with applicable securities laws. As part
of the repurchase program, the Company expects that it will enter into a
pre-arranged stock repurchase plan which would operate in accordance with
guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934.
Accordingly, transactions, if any, under the pre-arranged repurchase plan
would be effected in accordance with the terms of the stock repurchase plan,
including specified price, volume and timing conditions.

"Given the underlying strength of our business and the recent turbulence in
the equity markets, we believe the stock buy-back program is in the best
interests of our stockholders," Douglas C. Robinson, LifeVantage President and
CEO, stated. "We intend to implement this buyback program while maintaining
sufficient resources to continue to improve our balance sheet and invest in
future expansion opportunities."

The LifeVantage Corporation logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=11617

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
Words and expressions reflecting optimism, satisfaction or disappointment with
current prospects, as well as words such as "believe," "hopes," "intends,"
"estimates," "expects," "projects," "plans," "anticipates" and variations
thereof, identify forward-looking statements, but their absence does not mean
that a statement is not forward-looking. Examples of forward-looking
statements include, but are not limited to, statements we make regarding our
future prospects and our expectation that we will repurchase shares. Such
forward-looking statements are not guarantees of performance and the Company's
actual results could differ materially from those contained in such
statements. These forward-looking statements are based on the Company's
current expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that may cause
the Company's actual results or outcomes to be materially different from those
anticipated and discussed herein. These risks and uncertainties include, among
others, the potential failure or unintended negative consequences of the
implementation of the Company's network marketing sales channel; the Company's
ability to retain independent distributors or to attract new independent
distributors on an ongoing basis; the potential for third party and
governmental actions involving the Company's network marketing sales channel;
the potential for product liability claims against the Company; the risk that
government regulators and regulations could adversely affect the Company's
business; future laws or regulations may hinder or prohibit the production or
sale of the Company's existing product and any future products; unfavorable
publicity could materially hurt the Company's business; and the Company's
ability to protect its intellectual property rights and the value of its
product. These and other risk factors are discussed in greater detail in the
Company's Annual Report on Form 10-K and its Quarterly Report on Form 10-Q
under the caption "Risk Factors," and in other documents filed by the Company
from time to time with the Securities and Exchange Commission. The Company
cautions investors not to place undue reliance on the forward-looking
statements contained in this document. All forward-looking statements are
based on information currently available to the Company on the date hereof,
and the Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after the date
of this document, except as required by law.

CONTACT: Investor Relations Contact:
         Cindy England (801) 432-9036
         Director of Investor Relations
         -or-
         John Mills (310) 954-1105
         Senior Managing Director, ICR, LLC

company logo
 
Press spacebar to pause and continue. Press esc to stop.